China Launches First 128-Channel Fully Implantable Brain-Computer Interface Trial; Harbour BioMed Reveals AI Drug Preclinical Data
May 18, 2026 19:59
CST Updated
May 19, 10:07
Harbour BioMed
Antibody Drug Developer
Grit Biotherapeutics
Developer of Immunotherapy Drugs for Solid Tumors
Daiichi - Sankyo
Pharmaceutical Development, Production, Sales, and Consulting Service Provider
AstraZeneca
Pharmaceutical Technology Research and Development Provider